Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

B Jerome Zeldis


  • Director at Ptc Therapeutics Inc. (PTCT), 2020-01-31
  • Director at Soligenix Inc. (SNGX), 2019-11-19
  • Director at Biosig Technologies Inc. (BSGM), 2019-10-31
  • See Remarks at Sorrento Therapeutics Inc. (SRNE), 2018-11-28
  • at Metastat Inc. (MTST), 2017-11-22
  • Director at Alliqua Biomedical Inc. (ALQA), 2017-07-03
  • Director at Ait Therapeutics Inc. (AITB), 2017-04-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SNGX $0.93 2,000 Director 22,917 2019-11-19 Filing
SNGX $0.94 4,000 Director 20,917 2019-09-19 Filing
SNGX $0.73 10,000 Director 16,917 2019-04-22 Filing
MTST.OB $0.00 20,000 20,000 2017-04-04 Filing
ALQA $0.50 400,000 Director 686,750 2017-02-27 Filing